Universität Stuttgart
Permanent URI for this communityhttps://elib.uni-stuttgart.de/handle/11682/1
Browse
96 results
Search Results
Item Open Access Construction of robust Escherichia coli strains for large-scale production(2022) Ziegler, Martin; Takors, Ralf (Prof. Dr.-Ing.)The biotechnical production of many fine chemicals, proteins or pharmaceuticals depends on large-scale microbial cultivations. Due to limited mixing, heterogeneities in process relevant parameters such as nutrient concentrations arise in such fermentations. Escherichia coli (E. coli) is a model organism frequently used in the biotechnological industry. If E. coli is cultivated under heterogeneous conditions, biological reactions of the microorganism result in reduced process performance. Since large-scale fermentations are not economically feasible in academic settings, scale-down reactors that mimic aforementioned heterogeneities are used to investigate heterogenous fermentations. Previous studies in scale-down reactors unraveled that, depending on the process strategy, the unstable supply of a limiting primary carbon or nitrogen source such as glucose or ammonium is one of the underlying causes of process performance loss. Low concentrations of glucose or ammonium elicit the stringent response as a biological starvation reaction which comprises extensive transcriptional reactions. In the first project that contributes to this thesis, the regulatory and transcriptional reactions of the strains E. coli MG1655 and E. coli SR to repeated exposure to ammonium starvation zones were examined in a scale-down reactor. The scale-down reactor followed a two-compartment approach and consisted of a stirred tank reactor and a plug-flow reactor simulating passage through a starvation zone. E. coli SR is a strain with modulated stringent response. It was observed that short-term starvation stimuli do not trigger this regulatory program in E. coli SR and the transcriptional reaction was noticeably reduced. Long-term adaptation of the strain to repeated cycles of limitation and starvation also clearly differed from E. coli MG1655. Despite lack of the stringent response, E. coli SR showed no deficits in the assimilation of the limiting ammonium or in biomass yield on ammonium. In the second project of this thesis, a series of deletion strains with robust phenotype against glucose starvation zones were constructed. Candidate genes were identified and successively removed from the genome of E. coli MG1655 by Recombineering. The fundamental growth parameters of the strains were determined in shaking flask fermentations and no noticeable differences compared to E. coli MG1655 were found. Chemostat cultivations in a scale-down reactor with glucose as the limiting nutrient source revealed that the final strain of the deletion series, E. coli RM214, had a significantly lower maintenance coefficient under heterogeneous conditions than E. coli MG1655. Moreover, in an exemplary heterologous protein productionscenario E. coli RM214 rhaB- pJOE4056.2_tetA proved to be more robust to heterogeneities and showed a significantly higher product yield than E. coli MG1655 rhaB- pJOE4056.2_tetA. In the third project of this thesis, the production of pyruvate in E. coli MG1655 by inhibition of pyruvate dehydrogenase through CRISPR interference was investigated. A central goal was to achieve the stable production in nitrogen-limited conditions. For this, different target sequences in the operon pdhR-aceEF-lpd were tested and the strains cultivated in shaking flask fermentations. All tested target sequences were generally suitable to trigger the accumulation of pyruvate. Combined CRISPR interference against two target sequences did not lead to an increased pyruvate yield in most cases. In addition, the strains E. coli MG1655 pdCas9 psgRNA_aceE_234 and E. coli MG1655 pdCas9 psgRNA_aceE_234_pdhR_329 were characterized in two phase fermentations in lab-scale reactors. The initial phase was an unlimited exponential growth phase and was followed by an ammonium-limited production phase. E. coli MG1655 pdCas9 psgRNA_aceE_234 only produced pyruvate during the exponential phase, and reuptake of pyruvate occurred in the second phase. In contrast, E. coli MG1655 pdCas9 psgRNA_aceE_234_pdhR_329 stably produced pyruvate during the exponential and the ammonium-limited phase and is a potential chassis strain for the growth-decoupled production of pyruvate derived bioproducts. The overarching research issues of the projects were the characterization of strains in heterogeneous conditions and the development of new strategies to improve their performance. The collected data leads me to conclude that the construction of robust microbial strains for large-scale applications is both expedient and feasible. Tailored genetic modifications are the method of choice to achieve this goal. Furthermore, suitable genetic constructs offer promising possibilities for the stable growth-decoupled production of chemicals in nitrogen-limited conditions.Item Open Access Development of novel bispecific antibodies for cancer therapy targeting the receptor tyrosine kinases HER4 and EGFR(2024) Kühl, Lennart; Kontermann, Roland E. (Prof. Dr.)In this study, novel mono- and bispecific antibodies targeting the ErbB receptor family members EGFR and HER4 were investigated. Dual targeting of EGFR and HER4 by a bispecific, tetravalent antibody comprising a novel, antagonistic HER4-targeting antibody showed inhibition of proliferation and migration for a HB-EGF-stimulated ovarian cancer cell line. No inhibitory effects in a breast cancer cell line expressing EGFR and HER4 indicated that successful dual targeting does not solely rely on target expression. The complexity of HER4 with its isoforms and their different signaling properties makes HER4 a challenging cancer target that needs further in-depth research. To overcome resistances based on escape mutations located in the epitopes of clinically approved antibodies, novel antagonistic EGFR-targeting antibodies binding to a different epitope were developed. This epitope was mapped to domain III of EGFR and binding to clinically relevant EGFR ectodomain mutations resulted in inhibition of EGFR signaling in stable cell lines used as test systems. Favorable activities in comparison to clinically approved antibodies regarding inhibition of EGFR signaling and proliferation were observed for cancer cell lines expressing the EGFR wildtype. Bispecific T-cell engagers can lead to a T-cell mediated target cell killing independent of intracellular downstream signaling in the cancer cell. One challenge for the applicability of T-cell engagers in solid tumors is to keep the balance between T-cell mediated tumor cell killing and severe side-effects caused by a systemic activation of the immune system. Studies on eleven different eIg-based formats for EGFR-binding T-cell engagers showed that valency, geometry, and size influenced their activity profile. Furthermore, one bivalent and one trivalent, bispecific format were investigated for two novel EGFR-targeting moieties. As these molecules bind to clinically relevant escape mutations located in the ectodomain of EGFR, they are expected to show activity in patients with an acquired resistance to approved EGFR-targeting antibodies. These molecules led to a robust T-cell mediated cytotoxicity of cancer cells expressing EGFR. Additionally, benefits regarding an EGFR-level dependent cytotoxicity were observed for reduced binding to EGFR. An initial in vivo study using surrogate molecules in a syngeneic mouse model showed reduction of tumor growth and prolonged survival for treatment with a trivalent, bispecific T-cell engager comprising a novel EGFR-binding moiety. Taken together, beneficial effects of the novel molecules may contribute to improved therapies for patients with both pre-existing and acquired resistances to EGFR-targeting antibodies.Item Open Access Mechanistic studies on the DNA methyltransferases DNMT3A and DNMT3B(2021) Dukatz, Michael; Jeltsch, Albert (Prof. Dr.)In this work, both regulatory and catalytic mechanisms of de novo methyltransferases were investigated, which include interactions with other proteins and the specific recognition of the substrate sequence. Another part of this work strived to elucidate how enzymatic generation of 3-methylcytosine by DNMT3A can occur.Item Open Access Lokalisation, Speicherung und Synthese von Polyphosphat in Agrobacterium tumefaciens C58(2021) Hellenbroich, Celina; Jendrossek, Dieter (apl. Prof. Dr. rer. nat.)Polyphosphat (PolyP) besitzt eine ubiquitäre Verbreitung und erfüllt, je nach Organismus, unterschiedliche und extrem vielfältige Aufgaben. In Prokaryonten liegt PolyP in sogenannten Granula vor, während in einzelligen Eukaryonten, eine Membran das PolyP von dem Cytoplasma abtrennt. Vorangegangene Arbeiten weisen darauf hin, dass sogenannte Acidocalcisomen, eben jene membranumschlossene PolyP-Speicher aus Eukaryonten, auch in dem Bodenbakterium Agrobacterium tumefaciens vorhanden sein könnten. Die vorliegende Arbeit zeigt jedoch, dass sich in A. tumefaciens, wie in Bakterien übliche, PolyP-Granula befinden, die nicht von einer Membran umschlossen sind. Im weiteren Verlauf wurde die Synthese von PolyP sowie die Lokalisation der Polyphosphatkinasen (PPKs) und anderer aus der Literatur bekannter, PolyP-assoziierter Proteine untersucht. Die PPK1At stellte sich hierbei als PolyP-Syntheseenzym heraus. Es folgte eine biochemische Charakterisierung der PPKs in vitro, bei der für die PPK2At, neben der Bildung von NDP und NTP, eine oligophosphorylierende Funktion bis hin zu nonaphosphorylierten Nukleosiden entdeckt wurde. Außerdem stellte sich heraus, dass das PolyP-Granulum während des Zellzyklus wanderte und vielleicht durch die PPK1At mit der DNA assoziiert sein könnte. Aufgrund dieser Erkenntnisse konnte ein Modell des PolyP-Granulums und den in dieser Arbeit identifizierten, assoziierten Proteinen erstellt werden. Eine Deletion der ppk1 hatte zudem Auswirkungen auf die Zellmorphologie, die Infektionsrate von Pflanzenzellen und die Generationszeit von A. tumefaciens.Item Open Access Studien zur biotechnologischen Anwendung und ökologischen Funktion von Pyrrolochinolinchinon(PQQ)-abhängigen Alkoholdehydrogenasen(2021) Wehrmann, Matthias; Hauer, Bernhard (Prof. Dr.)Item Open Access Molecular dynamics simulations of the substrate- and product specificity and mechanism of DNA- and protein lysine methyltransferases(2024) Schnee, Philipp; Jeltsch, Albert (Prof. Dr.)Protein Lysine Methyltransferases (PKMTs) regulate the epigenetic code of cells and their alteration via somatic mutations are often associated with cancer. The aim of this project is to rationalize the product and substrate specificity of this enzyme family by a combination of biochemical experiments and molecular dynamics simulations. Based on this, a detailed view of the underlying mechanism behind the disease associated mutations shall be gained, which may provide new possibilities for personalized cancer therapies.Item Open Access Overcoming glioblastoma intractability : pre-clinical characterisation of TRAIL sensitisation by marizomib and novel treatment perspectives(2022) Boccellato, Chiara; Morrison, Markus (Prof. Dr.)Glioblastoma (GBM) is the most aggressive cancer of the central nervous system (CNS). Surgical resection, adjuvant temozolomide-based chemotherapy and radiation are the primary treatments, yet the outcome of GBM patients remains poor with a median life expectancy of 15 to 17 months. Therefore, novel and effective treatment options are required, as are reliable pre-clinical experimental models that are suitable for exploratory studies on novel drugs and drug combinations. In this work, patient-derived cell line models (PDCL), generated from fresh primary or recurrent glioblastoma tumours, have been examined to assess prevalence of responsiveness to a highly stable hexavalent format of TRAIL receptor agonist (IZI1551) and to the blood brain barrier (BBB)-permeant proteasome inhibitor marizomib (MRZ). Serum-free medium and limited cultivation times of both 2D and 3D cancer cell cultures were adopted to maintain the characteristics of primary tumour cells. The degree of BBB permeability of marizomib was evaluated in the human hCMEC/D3 cell line model, which was also employed to test the efficacy of the IZI1551+MRZ combination in pre-clinical settings. It was found that IZI1551 and marizomib acted synergistically to induce apoptosis in the majority of low-passage PDCLs, both under 2D and 3D cultivation conditions. Altering the relative timing of drug exposure, specifically marizomib pre-treatment, led to even enhanced responses and allowed to lower drug concentrations without losing treatment efficacy. Importantly, the amount of marizomib that can cross the simple BBB model was sufficient to confer sensitisation to IZI1551. In cases of treatment resistance against IZI1551 and marizomib, lowering the mitochondrial apoptosis threshold with BH3 mimetics appeared sufficient to restore apoptosis sensitivity. Taken together, these results demonstrated that marizomib is a potent sensitiser of apoptosis induced by a 2nd generation TRAIL receptor agonist in glioblastoma. The optimized synergism between marizomib and IZI1551 in time-shifted treatment schedules, together with the ability of marizomib to cross the BBB, suggests this combination as a promising strategy to be tested in clinical settings. In the second part of this work, an alternative cell death pathway, namely ferroptosis, has been investigated as a strategy to bypass the obstacle of the apoptosis refractory state of highly resistant cancers such as glioblastoma. Ferroptosis is a recently identified form of iron-dependent regulated cell death that presents distinct features compared to apoptosis and that is characterised by the accumulation of toxic lipid peroxides. Here it was shown that the U-87 MG, a bona-fide glioblastoma cell line that was reported to be TRAIL resistant, displays a dose-dependent cell death response to the ferroptosis inducer RSL3. Surprisingly, it was found that BH3 mimetics antagonised this cytotoxicity. The unexpected consequences of combining these agents highlight the need to better understand the interactions between these drugs in order to advance their use as cancer therapeutics. Overall, this thesis presents diverse treatment options against glioblastoma that exploit either drugs classically inducing apoptosis or the alternative cell death modality of ferroptosis. Considering the limited availability of approved treatments, studies aiming at expanding the choice of glioblastoma therapeutics, such as those conducted in this work, are of particular importance and pave the way for their implementation at a clinical and pre-clinical level.Item Open Access Funktionale und strukturelle Charakterisierung von Polyphosphat und Polyphosphat-assoziierten Proteinen im ß-Proteobakterium Ralstonia eutropha H16(2022) Rosigkeit, Hanna; Jendrossek, Dieter (Prof. Dr.)Item Open Access Entwicklung einer Methode zur Analyse der Tätigkeitsverteilung in Laborumgebungen der Lebenswissenschaften(Stuttgart : Fraunhofer Verlag, 2022) Castor, Jörg; Spath, Dieter (Univ.-Prof. Dr.-Ing. Dr.-Ing. E.h. Dr. h.c.)Laborarbeit der Lebenswissenschaften verändert sich. Wichtige Treiber sind dabei die Informatisierung und Automatisierung von Laborarbeit, die fachübergreifende Zusammenarbeit und Kommunikation sowie der steigende Anteil an wissensbasierter, theoretischer Arbeit. Die Auseinandersetzung mit Forschung und Praxis der Laborarbeit in den Lebenswissenschaften zeigte einen Mangel an wissenschaftlichen Erkenntnissen und Untersuchungen zu diesem Thema. Es existiert kein wissenschaftlicher Ansatz tätigkeitsbezogene Aspekte der lebenswissenschaftlichen Forschung und ihren Arbeitsorten systematisch zu untersuchen, um ein besseres Lagebild zur Arbeit in lebenswissenschaftlichen Laborumgebungen zu erhalten. Eine fundierte gestalterische Auseinandersetzung mit den prognostizierten und wahrnehmbaren Veränderungen von Laborarbeit kann so kaum erfolgen. Zielsetzung der vorliegenden Arbeit ist daher die Entwicklung einer wissenschaftlichen Methode zur Analyse der Tätigkeitsverteilung in Laborumgebungen der Lebenswissenschaften, um Anhaltspunkte für mögliche Fehlnutzungen, Verdrängungseffekte und andere Wirkungen im Spannungsfeld von Raum und Tätigkeiten zu bekommen. Die Methode ermöglicht zudem Aussagen zur Flächeneffizienz von Laborumgebungen. Der Begriff Laborumgebung beschreibt in der Arbeit den räumlichen Zusammenhang von Laboren mit Laborbänken, Laborabzügen, Schreib-/Auswerteplätzen, Sonderlaboren, Laborlagern sowie Büros und Kommunikationsflächen. Für die Anwendung der Methode werden jeweils nass-präparative Tätigkeiten, Schreib-, Lese- und Auswertetätigkeiten sowie Kommunikationstätigkeiten gebündelt. Kommunikationstätigkeiten werden eine besondere Relevanz in der modernen Forschungsarbeit zugeschrieben. Sie sind zudem die einzigen Tätigkeiten, die an allen Arbeitsorten in Laborumgebungen vorkommen. Als weitere Anwendung lässt die Methode daher eine Beurteilung der Qualität des raumbezogenen Informationsflusses und der tätigkeitsadäquaten Nutzung der Arbeitsorte in der Laborumgebung mittels eigener Qualitätsparameter für Kommunikation zu. In der praktischen Anwendung der Methode wird deutlich, dass die wissenschaftliche Herangehensweise gerade bei Einzeluntersuchungen einen gewissen Aufwand erfordert. Die Methode zeigte aber einen guten Praxisnutzen - insbesondere bei einer vergleichenden Untersuchung wie im Anwendungsbeispiel. So wurden durch die Vergleichsmöglichkeit im Anwendungsbeispiel sowohl Vorteile der effizienten Flächennutzung einer modernen »Multi-Space« Laborumgebung sichtbar, als auch die dadurch bedingten Schwierigkeiten hinsichtlich der Verdrängung raumtypischer Arbeitsweisen in dichteren räumlichen Funktionszusammenhängen.Item Open Access Resolving heterogeneities in single and multiphase bioreactor systems - Predictive modelling tools towards successful scale-up(2020) Kuschel, Maike; Takors, Ralf (Prof. Dr.-Ing.)